Financials SCYNEXIS, Inc.

Stocks

SCYX

US8112923094

Pharmaceuticals

Market Closed - 16:00:00 2026-10-07 EDT 5-day change 1st Jan Change
4.780 USD -1.24% Intraday chart for SCYNEXIS, Inc. +2.58% -5.52%

Projected Income Statement: SCYNEXIS, Inc.

Forecast Balance Sheet: SCYNEXIS, Inc.

Forecast Balance Sheet - SCYNEXIS, Inc.
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt - - - - - - - -
Change - - - - - - - -
Announcement Date 3/29/22 3/31/23 3/28/24 3/12/25 3/4/26 - - -
Estimates

Cash Flow Forecast: SCYNEXIS, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025
CAPEX 1 0.004 - - - - -
Change - - - - - -
Free Cash Flow (FCF) 1 -15.74 -50.43 -48.84 24.73 -10.81 0.5996
Change - -220.39% 3.14% 150.64% -143.7% 105.55%
Announcement Date 3/29/21 3/29/22 3/31/23 3/28/24 3/12/25 3/4/26
1USD in Million
Estimates

Forecast Financial Ratios: SCYNEXIS, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

         
EBITDA Margin (%) - - -1,672.58% - - - - - -
EBIT Margin (%) - -462.19% -1,684.48% 51.85% -990.84% -78.03% -6,509.28% -371.9% -163.04%
EBT Margin (%) - -273.14% -1,326.05% 47.94% -564.26% -41.79% -4,931.4% -485.67% -159.5%
Net margin (%) - -249.68% -1,233.73% 47.84% -568.29% -41.79% -4,931.4% -485.67% -159.5%
FCF margin (%) - - -1,657.57% - - - - - -
FCF / Net Income (%) - - 134.35% - - - - - -

Profitability

         
ROA -40.04% -34.2% -51.62% 42.01% -21.18% -13.42% - - -
ROE -309.57% -102.68% -282.34% 175.97% -33.25% -16.48% - - -

Financial Health

         
Leverage (Debt/EBITDA) - - - - - - - - -
Debt / Free cash flow - - - - - - - - -

Capital Intensity

         
CAPEX / Current Assets (%) - - - - - - - - -
CAPEX / EBITDA (%) - - - - - - - - -
CAPEX / FCF (%) - - - - - - - - -

Items per share

         
Cash flow per share 1 - - - - - - - - -
Change - - - - - - - - -
Dividend per Share 1 - - - - - - - - -
Change - - - - - - - - -
Book Value Per Share 1 - - - - - - - - -
Change - - - - - - - - -
EPS 1 - -10 -11.76 11.12 -3.52 -1.36 -2.91 -2.315 -1.66
Change - - -17.6% 194.56% -131.65% 61.36% -113.97% 20.45% 28.29%
Nbr of stocks (in thousands) - 3,565 4,082 4,651 4,744 5,246 9,950 9,950 9,950
Announcement Date - 3/29/22 3/31/23 3/28/24 3/12/25 3/4/26 - - -
1USD
Estimates
2026 *2027 *
P/E -1.66x -2.09x
PBR - -
EV / Sales 77.7x 7.21x
Yield - -

EPS & Dividend

EPS & Dividend - SCYNEXIS, Inc.


Y-o-Y evolution of P/E

Valuation ratios - P/E - SCYNEXIS, Inc.
 
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - SCYNEXIS, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.840USD
Average target price
36.33USD
Spread / Average Target
+650.69%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - SCYNEXIS, Inc.
  1. Stock Market
  2. Stocks
  3. SCYX Stock
  4. Financials SCYNEXIS, Inc.